Methadone Expansion in Detention Though the Hospital/Clinic Designation

计划入组 30 人 · 首次发布于 2026 年 7 月 16 日

Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

计划入组 75 人 · 首次发布于 2007 年 5 月 21 日

Increasing Donor Designation Rates in Teenagers: Effectiveness of a Driver's Education Intervention

计划入组 611 人 · 首次发布于 2017 年 1 月 9 日

FT-104

68Ga-NYM096

Synthetic Tumor-Specific Breakpoint Peptide Vaccine(BreakThrough Therapeutics)

METABOLIC THERAPY, INC.

United States

Everads Therapy Ltd.

Israel

ATI Physical Therapy

United States

Sunvozertinib Granted FDA Breakthrough Therapy Designation for First-Line EGFR Exon 20 Insertion-Positive NSCLC

Nipocalimab Receives Second FDA Breakthrough Therapy Designation for Sjögren's Disease

Replimune's RP1 Receives FDA Breakthrough Therapy Designation for Advanced Melanoma